[go: up one dir, main page]

AR025867A1 - PHARMACEUTICAL PORTASDORA FORMULATION - Google Patents

PHARMACEUTICAL PORTASDORA FORMULATION

Info

Publication number
AR025867A1
AR025867A1 ARP000105037A ARP000105037A AR025867A1 AR 025867 A1 AR025867 A1 AR 025867A1 AR P000105037 A ARP000105037 A AR P000105037A AR P000105037 A ARP000105037 A AR P000105037A AR 025867 A1 AR025867 A1 AR 025867A1
Authority
AR
Argentina
Prior art keywords
portasdora
formulation
pharmaceutical
portasdora formulation
pharmaceutical portasdora
Prior art date
Application number
ARP000105037A
Other languages
Spanish (es)
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of AR025867A1 publication Critical patent/AR025867A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ARP000105037A 1999-09-27 2000-09-26 PHARMACEUTICAL PORTASDORA FORMULATION AR025867A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40616499A 1999-09-27 1999-09-27

Publications (1)

Publication Number Publication Date
AR025867A1 true AR025867A1 (en) 2002-12-18

Family

ID=23606801

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000105037A AR025867A1 (en) 1999-09-27 2000-09-26 PHARMACEUTICAL PORTASDORA FORMULATION

Country Status (18)

Country Link
EP (1) EP1216029A1 (en)
JP (1) JP2003510267A (en)
KR (1) KR20020064289A (en)
CN (1) CN1399542A (en)
AR (1) AR025867A1 (en)
AU (1) AU7716100A (en)
BR (1) BR0014308A (en)
CA (1) CA2388471A1 (en)
CZ (1) CZ20021082A3 (en)
EA (1) EA200200415A1 (en)
HK (1) HK1044485A1 (en)
HU (1) HUP0202652A3 (en)
IL (1) IL148543A0 (en)
MX (1) MXPA02003190A (en)
NO (1) NO20021476L (en)
PL (1) PL354331A1 (en)
WO (1) WO2001022942A1 (en)
ZA (1) ZA200203311B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7138393B2 (en) 1998-07-24 2006-11-21 Wyeth Biologically active vasopressin agonist metabolites
US20030105144A1 (en) * 2001-04-17 2003-06-05 Ping Gao Stabilized oral pharmaceutical composition
WO2004073692A1 (en) * 2003-02-18 2004-09-02 Yamashita, Shinji Hard capsule of hardly water-soluble drug
CN100342856C (en) * 2003-04-10 2007-10-17 上海医药工业研究院 Composition of danazol semisolid skeleton preparation
JP5406529B2 (en) 2005-10-26 2014-02-05 バナー ファーマキャプス, インコーポレイテッド Dual controlled release matrix system based on lipophilic vehicle as capsule filler
CA2627292C (en) 2005-10-26 2012-04-17 Banner Pharmacaps, Inc. Hydrophilic vehicle-based dual controlled release matrix system
CL2007003146A1 (en) * 2006-10-31 2008-01-25 Wyeth Corp Pharmaceutical composition comprising a compound derived from indole and a carrier system comprising 15-25% of a viscosity improver, 5-15% of a solubilizer, 10-50% of a diluent and 1-10% of a stabilizer; Preparation process; and dosage form.
BR112020003233B1 (en) * 2017-12-20 2023-11-07 Firmenich S.A. COMPOSITIONS FOR ORAL CARE
EP4536229A1 (en) * 2022-06-13 2025-04-16 R.P. Scherer Technologies, LLC Enteric bisacodyl softgel capsule

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3636123A1 (en) * 1986-10-23 1988-05-05 Rentschler Arzneimittel ORAL ADMINISTRATIVE PREPARATIONS CONTAINING SINGLE DOSE FROM 10 TO 240 MG DIHYDROPYRIDINE
AU1911095A (en) * 1994-02-18 1995-09-04 Cephalon, Inc. Aqueous indolocarbazole solutions
CA2318128C (en) * 1998-01-20 2008-10-14 Applied Analytical Industries, Inc. Oral liquid compositions

Also Published As

Publication number Publication date
CN1399542A (en) 2003-02-26
ZA200203311B (en) 2003-12-31
NO20021476L (en) 2002-04-16
CA2388471A1 (en) 2001-04-05
JP2003510267A (en) 2003-03-18
HK1044485A1 (en) 2002-10-25
CZ20021082A3 (en) 2002-06-12
PL354331A1 (en) 2004-01-12
KR20020064289A (en) 2002-08-07
WO2001022942A1 (en) 2001-04-05
MXPA02003190A (en) 2002-09-30
NO20021476D0 (en) 2002-03-25
IL148543A0 (en) 2002-09-12
AU7716100A (en) 2001-04-30
HUP0202652A2 (en) 2004-05-28
BR0014308A (en) 2002-05-21
EA200200415A1 (en) 2002-10-31
EP1216029A1 (en) 2002-06-26
HUP0202652A3 (en) 2004-06-28

Similar Documents

Publication Publication Date Title
ITTO20010008A0 (en) PHARMACEUTICAL FORMULATION
FIU20000164U0 (en) New pharmaceutical formulation
NO20015175L (en) Pharmaceutical composition
PT1242087E (en) PHARMACEUTICAL COMPOSITIONS
NO992339D0 (en) Pharmaceutical Formulations
FI991485L (en) New pharmaceutical composition
ID24654A (en) OMEPRAZOLA PHARMACEUTICAL FORMULATION
NO20033384L (en) Pharmaceutical Formulation
NO20020086D0 (en) Flavor-masked pharmaceutical liquid formulations
NO20033785D0 (en) Pharmaceutical formulation
NO20015670D0 (en) Improved pharmaceutical formulations
NO20035627D0 (en) Pharmaceutical formulation
NO20022606D0 (en) Pharmaceutical combinations
NO20014926L (en) Pharmaceutical compounds
PT1239832E (en) PHARMACEUTICAL COMPOSITIONS
ID30032A (en) PHARMACEUTICAL FORMULATION
DK1227817T3 (en) Ciclesonide-containing aqueous pharmaceutical composition
AR025867A1 (en) PHARMACEUTICAL PORTASDORA FORMULATION
FI4488U1 (en) Pharmaceutical composition
NO20016430D0 (en) Pharmaceutical complex
NO20004816D0 (en) New pharmaceutical formulation
NO20021036L (en) Pharmaceutical preparation
SE9803952D0 (en) Pharmaceutical formulation
NO20041236L (en) Pharmaceutical Formulation
SE9901967D0 (en) New solid dosage formulation

Legal Events

Date Code Title Description
FB Suspension of granting procedure